Status:
COMPLETED
Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Lead Sponsor:
California Pacific Medical Center Research Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
University of California, San Francisco
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.
Eligibility Criteria
Inclusion
- Healthy males and females age 18-50
- Fluent English speaker
- Willing and able to give written consent
Exclusion
- Body mass index \> 30 or \< 18
- Pregnancy or lactation
- FOR MORE DETAILS CONTACT THE RESEARCH CLINIC.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00823407
Start Date
January 1 2009
End Date
July 1 2009
Last Update
May 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC Addiction & Pharmacology Research Laboratory (APRL)
San Francisco, California, United States, 94110